期刊文献+

Toll样受体4在多发性骨髓瘤患者外周血白细胞的表达及临床意义初探 被引量:3

Expression of Toll-like receptor 4 in peripheral blood of patients with multiple myeloma and its clinical significance
下载PDF
导出
摘要 为了探讨Toll样受体4(Toll-like receptor 4,TLR4)在外周血白细胞上的表达及其在多发性骨髓瘤中的意义。采用流式细胞术检测50例多发性骨髓瘤患者及35名健康对照者外周血淋巴细胞、单核细胞和中性粒细胞上TLR4的表达。结果TLR4在患者外周血淋巴细胞和中性粒细胞中的表达率较低;单核细胞TLR4阳性表达率在多发性骨髓瘤患者组为(24.71%±7.83%),显著低于健康对照组阳性率(43.14%±15.20%),差异有统计学意义(P<0.01),而TLR4在各型多发性骨髓瘤患者组的阳性表达率差异无统计学意义(P>0.05)。TLR4主要表达于外周血单核细胞,在多发性骨髓瘤患者中其阳性率降低,而且TLR4的阳性率高低与多发性骨髓瘤分型无关。表明TLR4及其介导的天然免疫应答与多发性骨髓瘤的发病存在一定的相关性。 To observe the differential expression of Toll-like receptor 4(TLR4) in peripheral blood of patients with multiple myeloma(MM) and to evaluate its clinical significance,the expressions of TLR4 in peripheral blood lymphocytes,monocytes and neutrophils of 50 cases of MM and 35 healthy individuals were assayed with flow cytometry.It was found the expression rate of TLR4 in peripheral blood monocytes of patients was high,but those in lymphocytes and neutrophils of patients were rather low.However,the positive e...
出处 《现代免疫学》 CAS CSCD 北大核心 2008年第3期241-243,共3页 Current Immunology
基金 科技部高科技863基金资助项目(2006AA02Z496) 国家自然科学基金资助项目(30471616)
关键词 多发性骨髓瘤 TOLL样受体 流式细胞术 multiple myeloma Toll-like receptor flow cytometry
  • 相关文献

参考文献8

  • 1[1]Akira S,Takeda K,Kaisho T.Toll-like receptors:critical proteins linking innate and acquired immunity[J].Nat Immunol,2001,2:675-680.
  • 2[2]Akira S,Hemmi H.Recognition of pathogen-associated molecular patterns by TLR family[J].Immunol Lett,2003,85:85-95.
  • 3[3]Akira S.Mammalian Toll-like receptors[J].Curr Opin Immunol,2003,15:238.
  • 4[4]Nakaya TA,Kita M,Kuriyana H.et al.Panax ginseng induces production of proinflamnmtory cytokines via Toll-like receptor[J].J Interferon Cytokine Res,2004,24:93-100.
  • 5[5]Smyth MJ,Godfrey DI,Trapani JA.A fresh look at tumor immunosurveillance and immunotherapy[J].Nat Immunol,2001,2:293-299.
  • 6[6]Biragyn A,Rufini PA,Leifer CA,et al.Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2[J].Science,2002,298:1025-1029.
  • 7[7]Jego G,Bataille R,Geffroy-Luseau A,et al.Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors[J].Leukemia,2006,20:1130-1137.
  • 8[8]Ishida I,Kubo H,Suzuki S,et al.Hypoxia diminishes Tolllike receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells[J].J lmmunol,2002,169:2069-2075.

同被引文献45

  • 1魏卫,包志明,袁保兰,刘妍.化学治疗前后血清可溶性Fas及FasL水平变化与肿瘤临床意义的关系[J].中国医师杂志,2006,8(3):404-405. 被引量:2
  • 2吴晖,黄雪珍,卢林,何鸿鸣,谢佐福,陈宁斌,王剑峰,陈道光.恶性淋巴瘤血清sApo-1/Fas检测及临床意义[J].实用肿瘤杂志,2006,21(2):138-140. 被引量:2
  • 3刘瑞玉,张舜玲,许先吟,钟伟强,巫远忠,余相,曹海燕,陈江涛,胡俊,陈立.多发性骨髓瘤患者血清IL-10、IL-12和sFas水平及其临床意义[J].国际医药卫生导报,2007,13(9):80-82. 被引量:3
  • 4Sheng PY,Konttinen L,Lehto M,et al.Revision total knee arthroplasty 1990-2002:Review of the Finnish Arthroplasty Register.J Bone Joint Surg Am.2006;88:1425-1430.
  • 5Sheng PY,J(a)msen E,Lehto M,et al.Revision total knee arthroplasty with the Total Condylar III system:a comparative analysis of 71 consecutive cases in patients with osteoarthritis or inflammatory arthritis.Acta Orthop.2006;77(3):512-518.
  • 6Sheng PY,J(a)msen E,Lehto MU,et al.Revision total knee arthroplasty with Total Condylar III system in inflammatory arthritis.J Bone Joint Surg Br.2005;87(9):1222-1224.
  • 7Sheng P,Lehto M,Kataja M,et al.Patient outcome following revision total knee arthroplasty:a meta-analysis.Int Orthop.2004;28(2):78-81.
  • 8Jamsen E,Sheng P,Halonen P,et al.Spacer prostheses in two-stage revision of infected knee arthroplasty.Int Orthop.2006;30(4):257-261.
  • 9Medzhitov R,Janeway CA Jr.Innate immune recognition:mechanisms and pathways.Immunol Rev.2000;173:89-97.
  • 10Aderem A,Ulevitch RJ.Toll-like receptors in the induction of the innate immune response.Nature.2000;406(6797):782-787.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部